NO20011309L - Benzotieno [3,2-c]pyridiner som<alfa>2-antagonister - Google Patents

Benzotieno [3,2-c]pyridiner som<alfa>2-antagonister

Info

Publication number
NO20011309L
NO20011309L NO20011309A NO20011309A NO20011309L NO 20011309 L NO20011309 L NO 20011309L NO 20011309 A NO20011309 A NO 20011309A NO 20011309 A NO20011309 A NO 20011309A NO 20011309 L NO20011309 L NO 20011309L
Authority
NO
Norway
Prior art keywords
benzotieno
pyridines
alfa
antagonists
Prior art date
Application number
NO20011309A
Other languages
English (en)
Norwegian (no)
Other versions
NO20011309D0 (no
Inventor
Ludo Edmond Josephine Kennis
Serge Maria Aloysius Pieters
Francois Paul Bischoff
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of NO20011309D0 publication Critical patent/NO20011309D0/no
Publication of NO20011309L publication Critical patent/NO20011309L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Emergency Medicine (AREA)
  • Psychology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
NO20011309A 1998-10-06 2001-03-15 Benzotieno [3,2-c]pyridiner som<alfa>2-antagonister NO20011309L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP98203363 1998-10-06
PCT/EP1999/007418 WO2000020422A1 (en) 1998-10-06 1999-10-01 BENZOTHIENO[3,2-c]PYRIDINES AS α2 ANTAGONISTS

Publications (2)

Publication Number Publication Date
NO20011309D0 NO20011309D0 (no) 2001-03-15
NO20011309L true NO20011309L (no) 2001-03-15

Family

ID=8234188

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20011309A NO20011309L (no) 1998-10-06 2001-03-15 Benzotieno [3,2-c]pyridiner som<alfa>2-antagonister

Country Status (28)

Country Link
US (2) US6426350B1 (zh)
EP (1) EP1117667B1 (zh)
JP (1) JP4580555B2 (zh)
KR (1) KR20010071828A (zh)
CN (1) CN1158287C (zh)
AR (1) AR023678A1 (zh)
AT (1) ATE363485T1 (zh)
AU (1) AU760226B2 (zh)
BG (1) BG64625B1 (zh)
BR (1) BR9913110A (zh)
CA (1) CA2346084C (zh)
CZ (1) CZ20011103A3 (zh)
DE (1) DE69936219T2 (zh)
EE (1) EE04835B1 (zh)
ES (1) ES2288025T3 (zh)
HK (1) HK1039113A1 (zh)
HU (1) HUP0103612A3 (zh)
ID (1) ID28280A (zh)
IL (2) IL142442A0 (zh)
NO (1) NO20011309L (zh)
NZ (1) NZ509911A (zh)
PL (1) PL347184A1 (zh)
RU (1) RU2222542C2 (zh)
SK (1) SK4312001A3 (zh)
TR (1) TR200100954T2 (zh)
TW (1) TWI251595B (zh)
UA (1) UA70334C2 (zh)
WO (1) WO2000020422A1 (zh)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE494000T1 (de) * 2002-03-08 2011-01-15 Max Planck Gesellschaft Verwendung von egfr transaktivierungsinhibitoren für menschlichen krebs
CA2480266C (en) * 2002-04-03 2011-07-12 Orion Corporation Use of an alpha2-adrenoreceptor antagonist for cns-related diseases
EP1757605A4 (en) 2004-04-12 2007-12-19 Taisho Pharmaceutical Co Ltd CYCLIC AMINE COMPOUND

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3752820A (en) * 1972-03-20 1973-08-14 Colgate Palmolive Co Substituted-1,2,3,4-tetrahydrobenzothieno(3,2-c)pyridine derivatives
FR2570701B1 (fr) * 1984-09-27 1987-05-22 Synthelabo Derives de furo(3,2-c)pyridines, leur preparation et leur application en therapeutique
US4686226A (en) * 1985-09-03 1987-08-11 Merck & Co., Inc. Substituted benzo[b]furo- and benzo[b]thieno quinolizines
EP0339959A3 (en) * 1988-04-27 1991-03-20 Glaxo Group Limited Lactam derivatives
US5100891A (en) * 1991-01-18 1992-03-31 Hoechst-Roussel Pharmaceuticals Inc. Substituted 1,2,3,4-tetrahydrocyclopent[b]indoles, 1,2,3,3a,4,8a-hexahydrocyclopent[B]indoles and related compounds
ATE247114T1 (de) * 1994-09-12 2003-08-15 Lilly Co Eli Serotonergische modulatoren
JP3274579B2 (ja) * 1995-01-12 2002-04-15 住友製薬株式会社 脳血管障害に伴う精神症候治療剤
UA52681C2 (uk) * 1997-04-08 2003-01-15 Янссен Фармацевтика Н.В. Похідні 1,2,3,4-тетрагідро-бензофуро[3,2,-c]піридину, спосіб їх одержання та фармацевтична композиція на їх основі

Also Published As

Publication number Publication date
DE69936219D1 (de) 2007-07-12
JP4580555B2 (ja) 2010-11-17
PL347184A1 (en) 2002-03-25
BG105331A (en) 2001-11-30
UA70334C2 (en) 2004-10-15
SK4312001A3 (en) 2001-12-03
AU760226B2 (en) 2003-05-08
CA2346084A1 (en) 2000-04-13
TR200100954T2 (tr) 2001-12-21
ID28280A (id) 2001-05-10
EP1117667B1 (en) 2007-05-30
WO2000020422A1 (en) 2000-04-13
US6426350B1 (en) 2002-07-30
HK1039113A1 (en) 2002-04-12
CZ20011103A3 (cs) 2001-12-12
IL142442A (en) 2006-10-05
EE04835B1 (et) 2007-06-15
EP1117667A1 (en) 2001-07-25
HUP0103612A3 (en) 2003-03-28
ATE363485T1 (de) 2007-06-15
KR20010071828A (ko) 2001-07-31
DE69936219T2 (de) 2008-02-07
NZ509911A (en) 2002-09-27
EE200100206A (et) 2002-06-17
US20020169178A1 (en) 2002-11-14
TWI251595B (en) 2006-03-21
IL142442A0 (en) 2002-03-10
CN1321159A (zh) 2001-11-07
ES2288025T3 (es) 2007-12-16
HUP0103612A2 (hu) 2002-01-28
AR023678A1 (es) 2002-09-04
RU2222542C2 (ru) 2004-01-27
NO20011309D0 (no) 2001-03-15
CA2346084C (en) 2010-01-26
CN1158287C (zh) 2004-07-21
JP2002526546A (ja) 2002-08-20
BG64625B1 (bg) 2005-09-30
US6774129B2 (en) 2004-08-10
BR9913110A (pt) 2001-05-08
AU6089999A (en) 2000-04-26

Similar Documents

Publication Publication Date Title
IS5721A (is) Pýróló [2,3-dl]pírimídín efnasambönd
ATE435861T1 (de) 12,13-cyclopropan-epothilonderivate
ID29241A (id) Turunan-turunan kinolin teranelasi-1,2
ID26698A (id) SENYAWA-SENYAWA PIROLO [2,3-d] PIRIMIDINA
NO20034576L (no) [Dihydro-benzo[b] [1,4] diazepin-2-on-derivater som MGLUR2- antagonister II
DE60019577D1 (de) 4, 5, 6, 7-tetrahydroindazolderivate als antitumormittel
ATE312819T1 (de) 4,4-biarylpiperidinederivate mit opioid-receptor- wirkung
SI1379522T1 (en) DIHYDRO-BENZO(b)(1,4)DIAZEPIN-2-ONE DERIVATIVES AS MGLUR2 ANTAGONISTS I
DE50107988D1 (de) Substituierte 1,2,3,4-tetrahydrochinolin-2-carbonsäurederivate
NO20003694D0 (no) VLA-4 antagonister
ATE204279T1 (de) Diaza-spiro(3,5)nonan-derivate
ID22131A (id) Turunan-turunan 1,2,3,4-tetrahidro-benzofuran [3,2-c] piridin
NO20003825D0 (no) 1,3,4 - oxadiazolonderivater
ATE317396T1 (de) 14,15-beta-methylen substituierte androgene
ID27845A (id) Turunan tetrahidrokuilina sebagai antagonis glisilina
NO20011270L (no) Tricykliske &lt;delta&gt;3-piperidiner som &lt;alfa&gt;2-antagonister
DK1075471T3 (da) Idolylderivater som serotonerge midler
ATE234839T1 (de) 4,5-azolo-oxindole
ID27686A (id) Turunan 3-(2-okso-[1,3]bipirolidinil-3-ildenametil)-sefem
NO20011309L (no) Benzotieno [3,2-c]pyridiner som&lt;alfa&gt;2-antagonister
NO20002575D0 (no) Substituerte oksimer som neurokininantagonister
IS5877A (is) Ný efnablanda
DE59909590D1 (de) Azidfreie, gaserzeugende zusammensetzung
DK0882044T3 (da) 1,4-dihydropyridinforbindelser som bradykinin-antagonister
PT1016404E (pt) Composicao aquosa de beta-caroteno

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application